1. Home
  2. ABR vs RAPP Comparison

ABR vs RAPP Comparison

Compare ABR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.93

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$38.29

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
RAPP
Founded
2003
2022
Country
United States
United States
Employees
653
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
ABR
RAPP
Price
$5.93
$38.29
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$9.90
$48.50
AVG Volume (30 Days)
4.0M
356.3K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
24.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$7.73
52 Week High
$12.58
$42.27

Technical Indicators

Market Signals
Indicator
ABR
RAPP
Relative Strength Index (RSI) 25.14 59.14
Support Level N/A $25.48
Resistance Level $8.15 $41.59
Average True Range (ATR) 0.33 2.30
MACD -0.25 0.07
Stochastic Oscillator 7.89 68.65

Price Performance

Historical Comparison
ABR
RAPP

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: